Characteristics | Current | Last year | P valuea |
---|---|---|---|
No. of patients | 42 | 18 | Â |
No. of aneurysms | 45 | 19 | Â |
Sex (male) | 24 (57.1) | 8 (44.4) | 0.366 |
Age, years | 54.9 ± 8.6 | 49.4 ± 10.7 | 0.039* |
Admission stratification | |||
 Normal patient | 34 (81.0) |  |  |
 Mild suspected patient | 8 (19.0) |  |  |
 Suspected patient | 0 (0.0) |  |  |
 Confirmed patient | 0 (0.0) |  |  |
COVID-19 NAT (n = 12) (negative) | 12 (100.0) | Â | Â |
False negative COVID-19 NAT | 0 (0.0) | Â | Â |
Location of responsible aneurysm | |||
 ACoA | 13 (31.0) | 7 (38.9) | 0.585 |
 PCoA | 15 (35.7) | 5 (27.8) | |
 ACA | 2 (4.8) | 0 (0.0) | |
 MCA | 11 (26.2) | 6 (33.3) | |
 Others | 1 (2.4) | 0 (0.0) | |
Fisher grade | 3.1 ± 1.1 | 2.9 ± 1.0 | 0.555 |
Modified Fisher grade | 3.0 ± 1.1 | 3.1 ± 1.1 | 0.835 |
Hunt-Hess grade | 1.9 ± 0.5 | 2.4 ± 0.6 | 0.003* |
WFNS grade | 2.7 ± 0.9 | 2.8 ± 1.1 | 0.690 |
GCS | 12.9 ± 1.2 | 12.0 ± 2.3 | 0.367 |
Duration between rupture and craniotomy, hours | 71.1 ± 55.2 | 40.7 ± 45.6 | 0.044* |
Duration between admission and craniotomy, hours | 37.1 ± 16.8 | 28.7 ± 11.7 | 0.058 |
Preoperative adverse events during hospitalization | |||
 Rebleeding | 0 (0.0) | 0 (0.0) | > 0.99 |
 Infarction | 0 (0.0) | 0 (0.0) | > 0.99 |
 Epilepsy | 2 (4.8) | 1 (5.6) | > 0.99 |
Duration of surgery, h | 3.5 ± 1.0 | 4.1 ± 2.3 | 0.277 |
Intraoperative blood loss, ml | 260.7 ± 238.0 | 258.3 ± 152.7 | 0.969 |
Mean hospital LOS, days | 14.9 ± 8.8 | 17.4 ± 6.9 | 0.298 |
Hospitalization cost, dollarsb | 13385.6 ± 6973.4 | 14006.1 ± 5640.4 | 0.740 |
Postoperative complications | |||
 Postoperative hemorrhage | 0 (0.0) | 1 (5.6) | 0.660 |
 Postoperative DCI | 13 (31.0) | 8 (44.4) | 0.315 |
 Postoperative DVT | 10 (23.8) | 1 (5.6) | 0.190 |
 Postoperative intracranial infection | 5 (11.9) | 4 (22.2) | 0.528 |
Discharge mRS score | |||
 Mean | 1.9 ± 1.6 | 2.1 ± 1.6 | 0.779 |
 0–2 | 29 (69.0) | 12 (66.7) | 0.856 |
 3–6 | 13 (31.0) | 6 (33.3) |